日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Triple HER2 Blockade With Trastuzumab, Pertuzumab, and Pyrotinib Versus Dual HER2 Blockade in the Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Randomized, Phase II Study

曲妥珠单抗、帕妥珠单抗和吡咯替尼三联HER2阻断疗法与HER2双联阻断疗法在HER2阳性乳腺癌新辅助治疗中的比较：一项随机II期研究

期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70611
Huang, Jiahui; Wang, Haoyu; Tong, Yiwei; Hong, Jin; Zhu, Yifei; Ren, Weili; Yu, Jing; Shi, Haoting; Gao, Weiqi; Zhu, Siji; Wu, Jiayi; Huang, Ou; Li, Jing; He, Jianrong; Chen, Weiguo; Li, Yafen; Shen, Kunwei; Chen, Xiaosong
肿瘤
乳腺癌
肿瘤免疫
HER2
发表日期：2026
文献求助 收藏

Aberrant lipid metabolism renders an aggressive behavior of T-lymphoblastic lymphoma in a MASH model.

在 MASH 模型中，异常的脂质代谢导致 T 淋巴母细胞淋巴瘤表现出侵袭性行为。

期刊:Oncogene
影响因子:7.3
doi:10.1038/s41388-025-03630-7
Guo Wei, Wang Xingtong, Cui Guozhen, Schmieder Emily A S, Gao Yonglin, Zhang Butian, Martin Robert C G, Bai Ou, Li Yan
淋巴瘤
细胞生物学
Mas
发表日期：2026
文献求助 收藏

Denosumab in pediatric patients with fibrous dysplasia/McCune-Albright syndrome: a single-center, open-labeled study

地诺单抗治疗儿童纤维性骨发育不良/McCune-Albright综合征：一项单中心、开放标签研究

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2026.1762370
Ouyang, Quanshi; Jiajue, Ruizhi; Zhou, Ruotong; Qi, Wenting; Li, Xiang; Cui, Lijia; Chi, Yue; Pang, Qianqian; Gong, Yiyi; Liu, Wei; Jiang, Yan; Wang, Ou; Li, Mei; Xing, Xiaoping; Xia, Weibo
发育与干细胞
发表日期：2026
文献求助 收藏

Characterization of High-Temperature, Low-Temperature and Fatigue Performance of Phosphogypsum Warm-Mix Asphalt

磷石膏温拌沥青的高温、低温和疲劳性能表征

期刊:Materials
影响因子:3.2
doi:10.3390/ma19040713
Jia, Xiaodong; Ou, Li; Zhu, Hongzhou
发表日期：2026
文献求助 收藏

Relationship Between Serum Nell-1 Level and Bone Geometry, Bone Microarchitecture in Chinese Postmenopausal Women

中国绝经后妇女血清Nell-1水平与骨几何结构、骨微结构的关系

期刊:International Journal of Endocrinology
影响因子:2.3
doi:10.1155/ije/9977862
Gong, Yiyi; Wu, Yushuo; Li, Xiang; Ma, Xiaosen; Ni, Xiaolin; Liu, Wei; Cui, Lijia; Chi, Yue; Jiajue, Ruizhi; Pang, Qianqian; Wang, Ou; Li, Mei; Xing, Xiaoping; Zhang, Zaizhu; Yu, Wei; Jiang, Yan; Xia, Weibo
发表日期：2026
文献求助 收藏

Efficacy of sequential denosumab after teriparatide for 6 months compared with denosumab monotherapy in reducing risk of osteoporotic fractures in patients with new fractures: a multicentre randomised controlled trial (STAND study) protocol

在接受特立帕肽治疗 6 个月后序贯使用地诺单抗与地诺单抗单药治疗相比，在降低新发骨折患者骨质疏松性骨折风险方面的疗效：一项多中心随机对照试验（STAND 研究）方案

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2025-111364
Chi, Yue; Zhu, Yidan; Yuan, Jie; Pang, Qianqian; Cui, Lijia; Jiang, Yan; Jiajue, Ruizhi; Liu, Wei; Wang, Ou; Li, Mei; Xing, Xiaoping; Li, Huijuan; Xie, Gaoqiang; Wu, Yangfeng; Xia, Weibo
代谢
骨折
骨质疏松
发表日期：2026
文献求助 收藏

Association of serum periostin with bone microarchitecture, muscle mass and function in Chinese postmenopausal women

中国绝经后妇女血清骨膜蛋白与骨微结构、肌肉量和功能的关系

期刊:American Journal of Translational Research
影响因子:1.6
doi:10.3389/fendo.2026.1808866
Mu, Zhixiang; He, Qingqing; Xin, Liangjing; Li, Yihan; Yuan, Shuai; Zou, Huawei; Shu, Linjing; Song, Jinlin; Huang, Yuanding; Chen, Tao; Gong, Yiyi; Wu, Yushuo; Ma, Xiaosen; Cui, Lijia; Li, Xiang; Pang, Qianqian; Chi, Yue; Jiajue, Ruizhi; Liu, Wei; Wang, Ou; Li, Mei; Xing, Xiaoping; Zhang, Zaizhu; Yu, Wei; Jiang, Yan; Xia, Weibo
发表日期：2026
文献求助 收藏

Clinical-transcriptomic classification of lumbar disc degeneration enhanced by machine learning

机器学习增强腰椎间盘退变的临床转录组分类

期刊:Military Medical Research
影响因子:22.9
doi:10.1186/s40779-025-00637-9
Jin, Huai-Jian; Lin, Peng; Ma, Xiao-Yuan; Huang, Sha; Zhang, Liang; Hu, Ou; Li, Yang-Yang; Wang, Ying-Bo; Zhu, Jun; Hu, Bo; Pu, Jun-Gang; Qin, Qin; Yan, Pu-Lin; Liu, Bing; Lan, Yu; Chen, Lin; Xie, Yang-Li; He, Jian; Gan, Yi-Bo; Liu, Peng
发表日期：2025
文献求助 收藏

Clinicopathological characteristics, genetic aberrations, and optimized treatment strategies in double-hit and triple-hit lymphoma: a multi-center cohort study

双重打击和三重打击淋巴瘤的临床病理特征、基因异常和优化治疗策略：一项多中心队列研究

期刊:Molecular Biomedicine
影响因子:10.1
doi:10.1186/s43556-025-00346-8
Shen, Yi-Ge; Ji, Meng-Meng; Shi, Qing; Wei, Xiao-Lei; Fan, Lei; Liu, Ting-Bo; Liu, Yao; Dong, Li-Hua; Liang, Ai-Bin; Huang, Liang; Zhou, Hui; Huang, Hong-Hui; Yang, Shen-Miao; Wang, Xiao-Bo; Tian, Yu-Yang; Zhu, Zun-Min; Bai, Ou; Li, Fei; Shi, Wen-Yu; Xu, Bin; Wang, Xin; Shi, Ke-Qian; Tang, Wei; Yi, Hong-Mei; Chen, Si-Yuan; Zheng, Zhong; Cheng, Shu; Xu, Peng-Peng; Zhao, Wei-Li; Wang, Li
淋巴瘤
发表日期：2025
文献求助 收藏

Phase 1b Multicenter Study of SG001, a Humanized Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors

SG001（一种人源化抗PD-1抗体）治疗晚期实体瘤患者的1b期多中心研究

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S546663
Fang, Jian; Jiang, Ou; Li, Wei; Lin, Jie; Fang, Meiyu; Li, Qun; Zhao, Weihong; Wang, Ke; Shi, Huaqiu; Chen, Zhendong; Yu, Junyan; Xing, Xiaojing; Zhao, Mingxuan; Liu, Anwen; Wang, Wei; Han, Zhengquan; Xiang, Silong; Zhang, Xiao; Li, Jin; Zhou, Caicun
Human
PD-1
发表日期：2025
文献求助 收藏